Elena Segala

发表

Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor

G. V. van Westen, A. IJzerman, E. Segala, 2021, Journal of medicinal chemistry.

Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals

Andrew S Doré, Robert M Cooke, Fiona H Marshall, 2018, Scientific Reports.

Towards high throughput GPCR crystallography: In Meso soaking of Adenosine A2A Receptor crystals.

E. Segala, R. Cheng, J. Errey, 2018 .

Kinetics for Drug Discovery: an industry-driven effort to target drug residence time.

Leigh A. Stoddart, R. Wade, R. Leurs, 2017, Drug discovery today.

Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.

A. IJzerman, E. Segala, D. Guo, 2016, Journal of medicinal chemistry.

ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections

E. Segala, M. Delledonne, E. Pomari, 2021, Genomics.

New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure

E. Segala, V. Jarlier, W. Sougakoff, 2012, Antimicrobial Agents and Chemotherapy.

Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.

E. Segala, R. Cheng, F. Deflorian, 2017, Structure.

Structural basis for CCR6 modulation by allosteric antagonists

P. Sahasrabudhe, A. Thorarensen, M. Schnute, 2024, bioRxiv.